David M. Livermore
University of East Anglia
K-1. Is antibiotic resistance stoppable?
Michael T. Osterholm
University of Minnesota
K-2. The Modern World of Infectious Diseases: A Growing Challenge
Jerome H. Kim
International Vaccine Institute
K-3. Vaccines for AMR: an Overview
Dennis M. Dixon
National Institute of Allergy and Infectious Diseases
K-4. Update on Actions and Opportunities on Antimicrobial Resistance at NIH/NIAID
David Paterson
National University of Singapore
P-1. Challenges in addressing the red plague of GNBs
Sara Cosgrove
Johns Hopkins University School of Medicine
P-2. Shaping Tomorrow's Antimicrobial Stewardship: The Crucial Contribution of Academic Institution
Jae-Hoon Song
Asia Pacific Foundation for Infectious Diseases
P-3. Artificial intelligence: A new weapon to fight infectious diseases
Vance G. Fowler
Duke University Medical Center
P-4. Research Progress on Persistent MRSA Infection
Jae-Joon Yim
Seoul National University College of Medicine
P-5. Current Status of Shorter Tuberculosis Treatment
Robin Patel
Mayo Clinic
P-6. Diagnostic Stewardship
Difficult-to-treat Pseudomonas aeruginsa & Carbapenem-resistant Acinetobacter
David M. Livermore
University of East Anglia
S1-1. Mechanisms and epidemiology of multiresistant non-fermenters
David Paterson
National University of Singapore
S1-2. Clinical implications and treatment of serious infections due to carbapenem resistant Pseudomonas aeruginosa
Anucha Apisarnthanarak
Thammasat University Hospital
S1-3. Epidemiology and Treatment of Serious Infections Due to Carbapenem Resistant Acinetobacter baumannii.
COVID-19
Helen Su
National Institute of Allergy and Infectious Diseases, National Institutes of Health
S2-1. Inborn errors of cytosolic RNA sensors and severe COVID-19
David Lye
National Centre for Infectious Diseases
S2-2. Vaccination in post-pandemic era and impact on long COVID
Sung-Han Kim
Asan Medical Center
S2-3. Viral shedding kinetics in patients with SARS-CoV-2 infection
Antimicrobial stewardship
Masayuki Maeda
Showa University, School of Pharmacy
S3-1. The current situation of Antimicrobial Stewardship Program in Asia-Pacific countries
Sara Cosgrove
Johns Hopkins University School of Medicine
S3-2. Cutting-Edge Antimicrobial Stewardship: Strategies for Optimizing Therapy and Curbing Resistance in the Modern Era
Se Yoon Park
Hanyang University Hospital
S3-3. Integrating Emerging Technologies: Pioneering the Next Frontier in Antimicrobial Stewardship
Strategies and Breakthroughs in the Battle Against Gram-Positive Bacterial Infections
Josh Davis
University of Newcastle, NSW
S4-1. Breaking New Ground in S. aureus Bacteremia: An Introduction to the SNAP Trial and Its Progress Thus Far
Vance G. Fowler
Duke University Medical Center
S4-2. Update in Staphylococcus aureus Bacteremia
Jaime Lora-Tamayo
Hospital Univ. 12 de Octubre, Madrid
S4-3. Periprosthetic Joint Infections caused by Staphylococcus aureus: current management approaches and antimicrobial strategies
Anton Y. Peleg
Alfred Hospital and Monash University
S4-4. From Bedside to Bench and Back Again for MRSA Therapeutics
Diagnostics 1
Arthur Jeng
UCLA School of Medicine, Olive View UCLA Medical Center
S5-1. Overview of Syndromic Testing: Rapid Multiplex PCR-guided Antimicrobial Stewardship and Clinical Benefits in Severe Infections (Pneumonia & Sepsis)
Tae Yeul Kim
Samsung Medical Center
S5-2. Syndromic testing of respiratory infections
Sung Jin Jo
Eunpyeong St. Mary’s Hospital
S5-3. Syndromic testing of gastrointestinal infections
Robin Patel
Mayo Clinic
S5-4. Syndromic testing of bone and joint infection
PK/PD
Eun Kyoung Chung
Kyung Hee University College of Pharmacy
S6-1. Antibiotic Therapy for Special Populations
Dong-Seok Yim
College of Medicine, The Catholic Univ of Korea
S6-2. Caution!: interpretation of plasma protein binding in PK/PD
Vincent H. Tam
University of Houston
S6-3. In vitro assessment of antimicrobial drug effect to guide personalized combination therapy.
Andrea René Jørgensen
Aarhus University Hospital
S6-4. Microdialysis for measurement of tissue antibiotic concentration
One health and antimicrobial resistance
Amanda Beaudoin
University of Minnesota
S7-1. One Health Antibiotic Stewardship
Mashkoor Mohsin
University of Agriculture, Faisalabad
S7-2. The transmission of antimicrobial resistance at the human-animal-environment interface with genomics
Gyu-Sung Cho
Max Rubner-Institut Federal Research Institute of Nutrition and Food
S7-3. International trends in research on antibiotic resistance from the perspective of One Health
Keun Seok Seo
College of Veterinary Medicine, Mississippi State University
S7-4. Phylogenomic Analysis of Carbapenem-resistant Enterobacterales in a Veterinary Hospital
Infection prevention and control 1: Updates in infection prevention practices & research
Stephan Harbarth
Geneva University Hospitals
S8-1. Back to the basics: hand hygiene update
Michael Klompas
Harvard Medical School
S8-2. Prevention of Non-Ventilator Hospital Acquired Pneumonia
Sun Young Cho
Samsung Medical Center
S8-3. Automation in the practice of infection prevention and control
Latest advances of microbiome research on infectious diseases
Bong-Soo Kim
Hallym University
S9-1. Understanding of human microbiome from an ecological perspective
Serena Porcari
IRCCS Fondazione Policlinico Universitario ‘Agostino Gemelli’
S9-2. Key determinants of success in fecal microbiota transplantation: from microbiome to clinic
Matthew Sorbara
University of Guelph
S9-3. Strategies to Restore Colonization Resistance with Microbiome-based Therapeutics
Viruses
Helen Y. Chu
University of Washington
S10-1. respiratory virus, RSV etc, maternal immunization
Cheng-Hsun Chiu
Chang Gung Memorial Hospital
S10-2. Bacterial-Viral Co-infection
Yae-Jean Kim
Samsung Medical Center
S10-3. Cytomegalovirus infection and drug resistance
Ji Yun Noh
Korea University College of Medicine
S10-4. Unveiling the hidden burden of respiratory virus infections in adult
Infection prevention and control 2: How to mitigate the risk using the environmental management
Jiwon Jung
Asan Medical Center
S11-1. How to mitigate multidrug resistant GNB spread through water control in healthcare settings
Anucha Apisarnthanarak
Thammasat University Hospital
S11-2. Control Clostridioides difficile in healthcare: what to consider?
Pyeong Gyun Choe
Seoul National University Hospital
S11-3. How to reduce the risk of MDR pathogens in ICUs using environmental design: single rooms are better?
Diagnostics 2
Ki Ho Hong
Yonsei University College of Medicine
S12-1. Clinical utility of biomarkers in infectious diseases
Dokyun Kim
Yonsei University College of Medicine
S12-2. Application of NGS in clinical microbiology and infection control
Po-Ren Hsueh
China Medical University, China Medical University Hospital
S12-3. Enhancing clinical impact of new parasitic disease detection technologies
Namhee Kim
SMG-SNU Boramae Medical Center
S12-4. Rapid detection of CPE: Enhancing patient treatment and infection control
Fungus: Antifungal Resistance; current trends and strategies to overcome
Jong Hee Shin
Chonnam National University Medical School
S13-1. Candida auris: epidemiology and antifungal resistance
Melissa Johnson
Duke University School of Medicine
S13-2. Antifungal stewardship in critically ill patients
Ilan Schwartz
Duke University School of Medicine
S13-3. The antifungal pipeline: advances in the treatment of invasive mycoses
The path that ends the era of HIV
Chien-Ching Hung
National Taiwan University Hospital Yunlin Branch
S14-1. Rapid ART initiation: why, how, and what to start
Chen Seong Wong
National Centre for Infectious Diseases
S14-2. Moving the needle: The role and impact of HIV self-testing on early diagnosis of HIV in Asia-Pacific
Jun Yong Choi
Yonsei University College of Medicine
S14-3. Pre-exposure prophylaxis: A pillar for ending the HIV epidemic
Vaccine
Benjamin Cowling
The University of Hong Kong
S15-1. Influenza vaccination strategies in older adults
Eui-Cheol Shin
KAIST Graduate School of Medical Science
S15-2. Understanding vaccine effectiveness in terms of T cell immunity
Ki Tae Kwon
Kyungpook National University School of Medicine
S15-3. Pneumococcal vaccination strategies in adult population
CRE
Hyukmin Lee
Severance Hospital, Yonsei University College of Medicine
W1-1. Epidemiology and Prevalence of CRE/CPE
Se Yoon Park
Hanyang University Hospital
W1-2. Survey on the Current State of CRE Antibiotic Treatment and Guidelines for Antibiotic Use in CRE Infections in Korea
Young Kyung Yoon
Korea University College of Medicine
W1-3. The reality of treatment for CRE/CPE infection in clinical setting in Korea
ASP
Ki Tae Kwon
Kyungpook National University School of Medicine
W2-1. Establishment of education system for experts training in antimicrobial stewardship program
Bongyoung Kim
Hanyang University College of Medicine
W2-2. Quantitative evaluation of antimicrobial use and feedback to individual hospitals: suggestion for the use of KONAS result
Yong Chan Kim
Yonsei University College of Medicine
W2-3. Evaluating Antimicrobial Utilization in Korean Long-Term Care Hospitals: A Call to Action for Antimicrobial Stewardship
CRAB
Seongman Bae
Asan Medical Center
W3-1. Combating CRAB: New Therapeutics and Treatment Strategies
Jung Wan Park
Soonchunhyang University Hospital Cheonan
W3-2. Preventing CRAB: Effective Infection Control Strategies
Big Data
Yujeong Kim
Review and Assessment Research Department, Health Insurance Review & Assessment Service
W4-1. Collaboration cases of RWD research in Health Insurance Review and Assessment(HIRA) Research Institute
Minkyung Han
Yonsei University College of Medicine
W4-2. Considerations for Clinical Studies Utilizing National Health Insurance Service Data
Hyeonjun Hwang
Kyungpook National University
W4-3. Insights into Collaborative Medical Data Research Driven by Data Science
To Be Updated